EcoDrugPlus

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSLCRG00005017768
Gene Symbol: GRM2B
3 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSLCRG00005002540
Gene Symbol: GRM3
3 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSLCRG00005003282
Gene Symbol: GRM5A
3 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSLCRG00005004019
Gene Symbol: GRM5B
3 Cross references
216 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSLCRG00005014400
Gene Symbol: GLSA
3 Cross references
228 Possible Orthologues:

Glutaminase B

Ensembl ID : ENSLCRG00005015363
Gene Symbol: GLSB
2 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSLCRG00005009414
Gene Symbol: GSK3AB
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSLCRG00005013639
Gene Symbol: GSK3BA
3 Cross references
222 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSLCRG00005002629
Gene Symbol: LOC104931591
3 Cross references
187 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSLCRG00005014506
Gene Symbol: GNRHR1
3 Cross references
135 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSLCRG00005017876
Gene Symbol: LOC104937089
2 Cross references
155 Possible Orthologues:

Granzyme B(G,h)

Ensembl ID : ENSLCRG00005013858
Gene Symbol: LOC104918775
2 Cross references
929 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).